drugset

drugset / Trial / NCT00623701

Efficacy and Safety From a High-dosed Sublingual Grass Pollen Preparation

NCT00623701 ↗

Phase 3 Completed 126 enrolled Allergopharma GmbH & Co. KG

RandomizedParallel-groupDouble-blindTreatment

Summary

Efficacy and Safety from a high-dosed sublingual grass pollen preparation

Timeline

Start: 2008-03
Primary completion: 2011-10
Completion: 2012-10

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Allerslit forte	Unknown	40 ug	Other

Indications